about
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates includ...
Read More
14.61
-0.13
(-0.88%)
88,365.2
XNAS Volume
XNAS 11 May, 2026 1:23 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Mesoblast Ltd (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..